Skip to main content
Equibles

Velan Capital Investment Management LP

Position in TENX — Tenax Therapeutics, Inc.

CIK 1848809 ALPHARETTA, GA
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,002,281
-$1,325,213 QoQ
Shares Held
549,985
-5.7% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
4.90%
of 13F equity value
Holder Rank
#17
of 111 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Derivatives in TENX

reported options exposure · as of Jun 30, 2026
CallValue
$999,585
CallShares
68,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. TENX ranks #7 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 88,781 $29,722,990
2 MPLT
MapLight Therapeutics, Inc.
 492,893 $17,665,285
3 STRO
Sutro Biopharma, Inc.
 512,160 $17,003,712
4 IMMX
Immix Biopharma, Inc.
 1,085,000 $11,186,350
5 TARA
Protara Therapeutics, Inc.
 2,844,652 $10,866,570
6 ABVX
Abivax S.A.
 65,630 $8,745,853
7 TENX
Tenax Therapeutics, Inc.
This page 		549,985 $8,002,281
8 EDSA
Edesa Biotech, Inc.
 827,500 $6,727,575

All Filings in TENX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $999,585 68,700
2026-06-30 $8,002,281 549,985
2026-03-31 $9,327,494 583,333
2025-12-31 $1,015,829 83,333
2025-09-30 $634,164 83,333
2025-06-30 $479,998 83,333
2025-03-31 $545,831 83,333
2024-12-31 $515,831 83,333
2024-09-30 $288,332 83,333